2021 法国建议:Takayasu动脉炎的管理

2021-07-21 国外风湿免疫科相关专家小组 Orphanet J Rare Dis.2021 Jul 21;16(Suppl 3):311.

Takayasu动脉炎是血管炎的一部分,作为影响大口径血管的炎症,过去称为无脉疾病或主动脉弓综合征。本文主要介绍了当前Takayasu动脉炎的诊断以及药物治疗的相关内容。

中文标题:

2021 法国建议:Takayasu动脉炎的管理

英文标题:

French recommendations for the management of Takayasu's arteritis

发布日期:

2021-07-21

简要介绍:

Takayasu动脉炎是血管炎的一部分,作为影响大口径血管的炎症,过去称为无脉疾病或主动脉弓综合征。本文主要介绍了当前Takayasu动脉炎的诊断以及药物治疗的相关内容。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 法国建议:Takayasu动脉炎的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0c7b61c0021a0166, title=2021 法国建议:Takayasu动脉炎的管理, enTitle=French recommendations for the management of Takayasu's arteritis, guiderFrom=Orphanet J Rare Dis.2021 Jul 21;16(Suppl 3):311., authorId=0, author=, summary=Takayasu动脉炎是血管炎的一部分,作为影响大口径血管的炎症,过去称为无脉疾病或主动脉弓综合征。本文主要介绍了当前Takayasu动脉炎的诊断以及药物治疗的相关内容。, cover=https://img.medsci.cn/2021729/1627489036709_2020535.jpg, journalId=0, articlesId=null, associationId=893, associationName=国外风湿免疫科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jul 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>Takayasu动脉炎是血管炎的一部分,作为影响大口径血管的炎症,过去称为无脉疾病或主动脉弓综合征。本文主要介绍了当前Takayasu动脉炎的诊断以及药物治疗的相关内容。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=32381, tagName=动脉炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=32381, guiderKeyword=动脉炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7218, appHits=88, showAppHits=0, pcHits=1241, showPcHits=7129, likes=1, shares=12, comments=9, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-07-21, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 29 00:17:27 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 18:05:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 法国建议:Takayasu动脉炎的管理.pdf)])
2021 法国建议:Takayasu动脉炎的管理.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1075012, encodeId=ad3310e501265, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec675553013, createdName=线标, createdTime=Mon Nov 29 10:44:56 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056758, encodeId=37871056e58df, content=期待有翻译版本。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:11:04 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055384, encodeId=c4c71055384fb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:28:05 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051871, encodeId=928810518e1ba, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:34:33 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005818, encodeId=43ba1005818a4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c475533782, createdName=ymyymyymy, createdTime=Sat Aug 07 15:02:21 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-11-29 线标

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1075012, encodeId=ad3310e501265, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec675553013, createdName=线标, createdTime=Mon Nov 29 10:44:56 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056758, encodeId=37871056e58df, content=期待有翻译版本。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:11:04 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055384, encodeId=c4c71055384fb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:28:05 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051871, encodeId=928810518e1ba, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:34:33 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005818, encodeId=43ba1005818a4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c475533782, createdName=ymyymyymy, createdTime=Sat Aug 07 15:02:21 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-10-01 13f0c37dm61暂无昵称

    期待有翻译版本。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1075012, encodeId=ad3310e501265, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec675553013, createdName=线标, createdTime=Mon Nov 29 10:44:56 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056758, encodeId=37871056e58df, content=期待有翻译版本。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:11:04 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055384, encodeId=c4c71055384fb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:28:05 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051871, encodeId=928810518e1ba, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:34:33 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005818, encodeId=43ba1005818a4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c475533782, createdName=ymyymyymy, createdTime=Sat Aug 07 15:02:21 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-09-27 13f0c37dm61暂无昵称

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1075012, encodeId=ad3310e501265, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec675553013, createdName=线标, createdTime=Mon Nov 29 10:44:56 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056758, encodeId=37871056e58df, content=期待有翻译版本。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:11:04 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055384, encodeId=c4c71055384fb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:28:05 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051871, encodeId=928810518e1ba, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:34:33 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005818, encodeId=43ba1005818a4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c475533782, createdName=ymyymyymy, createdTime=Sat Aug 07 15:02:21 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1075012, encodeId=ad3310e501265, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec675553013, createdName=线标, createdTime=Mon Nov 29 10:44:56 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056758, encodeId=37871056e58df, content=期待有翻译版本。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:11:04 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055384, encodeId=c4c71055384fb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:28:05 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051871, encodeId=928810518e1ba, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:34:33 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005818, encodeId=43ba1005818a4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c475533782, createdName=ymyymyymy, createdTime=Sat Aug 07 15:02:21 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-08-07 ymyymyymy

    学习了

    0

拓展阅读

2010 BSR/BHPR 巨细胞动脉炎治疗指南

英国风湿病学会(BSR,British Society for Rheumatology) · 2010-01-01

2008EULAR/ PRINTO/ PRES 过敏性紫癜、儿童结节性多动脉炎、儿童韦格纳肉芽肿、儿童多发性大动脉炎标准(第二部分):分类标准

儿童风湿病国际试验组织(PRITO,Pediatric Rheumatology International Trials Organisation) · 2010-01-01

2008EULAR/PRITO/PRES 过敏性紫癜、儿童结节性多动脉炎、儿童韦格纳肉芽肿、儿童多发性大动脉炎标准(第一部分):最终分类标准

儿童风湿病国际试验组织(PRITO,Pediatric Rheumatology International Trials Organisation) · 2010-04-13

2011 大动脉炎诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2011-02-01

2011 中国 结节性多动脉炎诊断和治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2011-03-01

2011 风湿性多肌痛和巨细胞动脉炎诊断和治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2011-05-01